Clips on 'vaccines'

A COVID-19 Vaccine Will Take 12+ Months to Develop

3:15 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

COVID-19 Isn't Going Away; People Will Need Updated Vaccines

0:47 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

COVID-19 Vaccine Efficacy Rates: Why J&J's Is Lower Than Moderna & Pfizer's

1:46 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

How to Choose Between Moderna, Pfizer, and J&J's COVID-19 Vaccine

2:06 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

COVID-19 Vaccines Could Be Tweaked to Ward Off Coronavirus Variants

1:37 · The Intensifying Race Between Coronavirus Variants And Vaccines - Audie Cornishview episode

Coronavirus Daily
play_arrow pause

Anthony Fauci Is Optimistic About Widespread COVID-19 Vaccine Availability By April 2021

0:31 · America's Vaccine Plan: What's Working — And What Isn't - Audie Cornishview episode

Coronavirus Daily
play_arrow pause

Moderna & Pfizer's COVID-19 Vaccines Are of the mRNA Form

2:39 · COVID-19 Vaccine 101 and Inequality in Vaccine Distribution With Dr. Ebony Hilton-Buchholz - Ebony Jade Hilton, MDview episode

The Bakari Sellers Podcast
play_arrow pause

COVID-19 Vaccines Can Cause a Mild Immune Response

1:29 · COVID-19 Vaccine 101 and Inequality in Vaccine Distribution With Dr. Ebony Hilton-Buchholz - Ebony Jade Hilton, MDview episode

The Bakari Sellers Podcast
play_arrow pause

Will Shipping COVID-19 Vaccines on Dry Ice Pose Challenges?

1:35 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Moderna COVID-19 Vaccine Enters Phase III Clinical Trial

3:15 · First Phase III Vaccine Trial Underway, Government Seeks Thousands Of Volunteersview episode

Coronavirus Daily
play_arrow pause

Three COVID-19 Vaccine Candidates Could Begin Clinical Trials This Summer

0:57 · Numbers Steady, Hundreds More Dead Each Day; The Cost Of Opening Schoolsview episode

Coronavirus Daily
play_arrow pause
Coronavirus Daily
play_arrow pause

Countries Are Racing to Develop a COVID-19 Vaccine

1:34 · Global Vaccine Competition; More Than 100,000 Deadview episode

Coronavirus Daily
play_arrow pause

COVID-19 Vaccine Research Shows Antibody Response Correlates With Protection Extent

1:13 · Optimism For A Vaccine; Strapped Unemployment Offices Leave Many Waitingview episode

Coronavirus Daily
play_arrow pause

Multiple COVID-19 Vaccines Are Being Fast-Tracked

0:20 · Testing, Reopening Schools, Vaccines: Fauci And Others Testifyview episode

Coronavirus Daily
play_arrow pause

If You're Obese, a COVID-19 Vaccine May Not Be Effective

2:32 · Waiting for THE vaccine? Science you must know - Mike Mutzel, MSview episode

High Intensity Health Radio with Mike Mutzel, MS
play_arrow pause

A COVID-19 Vaccine Would Likely Face Manufacturing Challenges

2:21 · Michael Osterholm, Ph.D.: COVID-19—Lessons learned, challenges ahead, and reasons for optimism and concernview episode

The Peter Attia Drive
play_arrow pause

Scott Galloway: Vaccines Are the Best Trade in Modern Medicine

1:25 · The crypto-surge, Bernie Madoff's dark legacy, and a question on Russia slowing Twitter - Scott Gallowayview episode

Pivot with Kara Swisher and Scott Galloway
play_arrow pause

Moderna, Pfizer, and J&J's COVID-19 Vaccines Aren't the Same — But They're All Effective

1:01 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

Comparing Efficacy Rates Between Moderna, Pfizer, & J&J COVID-19 Vaccines Is Difficult

0:43 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

COVID-19 Vaccines Were Produced at an Unprecedented Speed

0:34 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

J&J, Moderna, & Pfizer COVID-19 Vaccines Exceed Emergency Use Authorization Benchmark

0:36 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

US Government Wanted COVID-19 Vaccines to Cause a 50% Reduction in Symptomatic Illness

1:33 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

J&J's COVID-19 Vaccine Is Single-Shot & Doesn't Require Cold Storage

0:56 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

J&J's Single-Shot Vaccine Is 85% Efficacy Against Severe COVID-19

0:53 · The Third Vaccine, and Vaccine Choice - Jorge Conde, Lauren Richardson, Ph.Dview episode

a16z
play_arrow pause

Naval Ravikant Was Disappointed in the US' COVID-19 Vaccine Response

0:35 · #504: Vitalik Buterin, Creator of Ethereum, on Understanding Ethereum, ETH vs. BTC, ETH2, Scaling Plans and Timelines, NFTs, Future Considerations, Life Extension, and More (Featuring Naval Ravikantview episode)

The Tim Ferriss Show
play_arrow pause

Will COVID-19 Vaccines Drive Coronavirus Mutations?

3:53 · The Intensifying Race Between Coronavirus Variants And Vaccines - Audie Cornishview episode

Coronavirus Daily
play_arrow pause

Tennessee's COVID-19 Vaccine Distribution Relies on the Honor System

2:48 · America's Vaccine Plan: What's Working — And What Isn't - Audie Cornishview episode

Coronavirus Daily
play_arrow pause

Biden Administration Will Release All Available COVID-19 Vaccine Doses

1:23 · America's Vaccine Plan: What's Working — And What Isn't - Audie Cornishview episode

Coronavirus Daily
play_arrow pause

Will COVID-19 Vaccines Protect Against Mutant SARS-CoV-2 Strains?

1:02 · COVID-19 Vaccine 101 and Inequality in Vaccine Distribution With Dr. Ebony Hilton-Buchholz - Ebony Jade Hilton, MDview episode

The Bakari Sellers Podcast
play_arrow pause

A Second Dose of Pfizer & Moderna's COVID-19 Vaccines Increases Efficacy

0:59 · COVID-19 Vaccine 101 and Inequality in Vaccine Distribution With Dr. Ebony Hilton-Buchholz - Ebony Jade Hilton, MDview episode

The Bakari Sellers Podcast
play_arrow pause

Pfizer & Moderna's COVID-19 Vaccines Have Different Storage Temperatures

1:04 · COVID-19 Vaccine 101 and Inequality in Vaccine Distribution With Dr. Ebony Hilton-Buchholz - Ebony Jade Hilton, MDview episode

The Bakari Sellers Podcast
play_arrow pause

What Opportunities Is Salesforce Exploring as COVID-19 Vaccines Near Distribution?

1:11 · Rapid Response: Why Salesforce Bought Slack, w/Salesforce's Bret Taylorview episode

Masters of Scale with Reid Hoffman
play_arrow pause

COVID-19 Treatment Strategies Have Improved Since March 2020

1:08 · BONUS: How Effective Are Antibody Treatments For COVID-19? - Richard Harrisview episode

Coronavirus Daily
play_arrow pause

How Will Dr. Robert Atmar Persuade Others to Get the COVID-19 Vaccine?

0:57 · Fauci Predicts Widespread Vaccine Availability By April. Are Americans Ready?view episode

Coronavirus Daily
play_arrow pause

Which Types of COVID-19 Vaccines Will Pose the Most Risk?

2:07 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Will SARS-CoV-2 Mutate & Make Vaccines Ineffective?

3:08 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Companies Are Applying an mRNA Strategy to Coronavirus Vaccines

2:07 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Given RNA's Instability, mRNA Vaccines Must Be Stored at Low Temperatures

1:31 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

To Prove Effective, COVID-19 Vaccines Must Prevent SARS-CoV-2 from Binding to Cells

0:41 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Sanofi/GSK & Novavax Are Nearing Phase III Trials for Their COVID-19 Vaccines

0:27 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Dr. Paul Offit Explains How Preclinical & Phase I-III Trials Apply to Vaccines

4:53 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

All Inactivated COVID-19 Vaccines Are Being Made in China

0:37 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Paul Is Confident the First COVID-19 Vaccines Will Be Safe & Effective

2:19 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Post-Market Surveillance Is Essential for COVID-19 Vaccines

1:17 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Russia & China Approved COVID-19 Vaccines Despite Limited Data

1:34 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Paul Is Outraged at Andrew Wakefield for Starting the Anti-Vaccine Movement

3:26 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Don't Be Nervous About COVID-19 Antibodies Fading Over Time

2:23 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Paul Offit Spent 26 Years Developing the Rotavirus Vaccine

1:13 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

When Does Paul Expect COVID-19 Vaccine Efficacy Data to Be Made Public?

3:54 · Paul Offit, M.D.: An expert perspective on COVID-19 vaccinesview episode

The Peter Attia Drive
play_arrow pause

Multiple COVID-19 Vaccines Are Nearing Approval

1:24 · Rapid Response: Nothing matters but this. w/Eric Schmidt (frmr Google CEO)view episode

Masters of Scale with Reid Hoffman
play_arrow pause

1 in 3 Americans Wouldn't Get a COVID-19 Vaccine Approved By the FDA

0:55 · Why Are So Many Americans Hesitant To Get A COVID-19 Vaccine?view episode

Coronavirus Daily
play_arrow pause

Peter Attia Predicts the Safety & Risk Profile of a Potential COVID-19 Vaccine

2:00 · Matthew Walker, Ph.D.: Sleep and immune function, chronotypes, hygiene tips, and addressing questions about his bookview episode

The Peter Attia Drive
play_arrow pause
ms